Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks [NA]

View source ↗

Summary

This Clinical Trial Update describes the immune response in breast cancer patients treated with levobupivacaine via paravertebral or superficial chest blocks; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • levobupivacaine (levobupivacaine)

Snippet

Sponsor: University of Rijeka | Conditions: Paravertebral Block, Pectoralis and Serratus Plane Nerve Blocks | NA | Status: ACTIVE_NOT_RECRUITING